denileukin diftitox-cxdl
denileukin diftitox-cxdl is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including LYMPHIR. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- denileukin diftitox-cxdl
- Brand Names
- LYMPHIR
- Application Number
- BLA761312
- Sponsor
- Citius Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- DENILEUKIN DIFTITOX
Indications and Usage
1 INDICATIONS AND USAGE LYMPHIR is indicated for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy. LYMPHIR is an IL2-receptor-directed cytotoxin indicated for the treatment of adult patients with relapsed or refractory Stage I-III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy. ( 1 )